An alternative splice variant of human IL-4, IL-4δ2, inhibits IL-4-stimulated T cell proliferation

Journal of Immunology

Volumn 156, Issue 2, 1996, Pages 435-441

  Atamas, Sergei P ^a,c   Choi, Jung ^a   Yurovsky, Vladimir V ^a   White, Barbara ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CONFORMATIONAL TRANSITION; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; OPEN READING FRAME; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANTIGENS, CD; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CLONING, MOLECULAR; DEPRESSION, CHEMICAL; DNA, COMPLEMENTARY; EXONS; HUMANS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; ORGAN SPECIFICITY; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-4; RECOMBINANT FUSION PROTEINS; RESPIRATORY SYSTEM; RNA SPLICING; RNA, MESSENGER; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0030052465     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Howard, M., J Farrar, M Hilfiker, B. Johnson, K Takatsu, T Hamaoka, and W E. Paul. 1982. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155:914.
2. Brown, M. A., J. H. Pierce, C. J Watson, J. Falco, J N. Ihle, and W. E. Paul 1987. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50:809
3. MacGlashan, D., J. M. White, S -K. Huang, S. J. Ono, J. T. Schroeder, and L. M Lichtenstein 1994 Secretion of IL-4 from human basophils. J. Immunol. 152 3006
4. Illera, V. A., C. E. Perdandones, L L. Stunz, D. A. Mower, Jr., and R. F. Ashman 1993. Apoptosis in splenic B lymphocytes: regulation by protein kinase C and IL-4 J. Immunol. 151:3521.
5. Banchereau, J., C. Bidaud, A. C. Fluckiger, L. Galibert, P. Garrone, F. Malisan, and D. Pandrau 1993. Effects of interleukin 4 on human B cell growth and differentiation. Res. Immunol 144 601.
6. Renz, H., J. Domenico, and E W. Gelfand. 1991. IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells. J Immunol. 146:3049.
7. Romagnani, S. 1993. Regulatory role of IL-4 and other cytokines in the function and development of human T cell clones. Res. Immunol. 144:625.
8. Mosmann, T. R., M W. Bond, R. L Coffman, J. Ohara, and W. E Paul. 1986 T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83:5654.
9. Fernandez-Botran, R , P H. Krammer, T. Diamantstein, J. W. Uh, and E. S. Vitetta. 1986. B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines. J Exp. Med 164:580.
10. Mitchell, L. C., L. S. Davis, and P. E Lipsky. 1989. Promotion of human T lymphocyte proliferation by IL-4. J. Immunol 142:1548.
11. Le Gros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells J. Exp. Med. 172:921.
12. Crawford, R. M , D. S. Finbloom, J. Ohara, W. E. Paul, and M. S. Meltzer 1987 B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J. Immunol. 139.135.
13. Peschell C., W. E. Paul, J Ohara, and I. Green 1987. Effects of B-cell stimulatory factor/interleukin-4 on hematopoietic progenitor cells. Blood 70:254
14. Feghali, C. A., K L. Bost, D. W. Boulware, and L S. Levy. 1992. Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts Clin Immunol. Immunopathol 63:182.
15. Postlethewaite, A. E , and J. M Seyer. 1991. Fibroblast chemotaxis induced by human recombinant interleukin-4: identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122 J. Clin. Invest. 87:2147.
16. Postlethewaite, A., M A. Holness, H. Katai, and R. Raghow. 1992. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest 90:1479.
17. Piela-Smith, T. H., G. Broketa, A. Hand, and J. H Korn 1992. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J. Immunol 148:1375.
18. Miossec, P., P. Chomarat, J. Dechanet, J.-F. Moreau, J.-P. Roux, P. Delmas, and J Banchereau 1994 Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines m an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 37:1715.
19. Scott, P., P. Natovitz, R. L. Coffman, E Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med 168 1675
20. Heinzel, F. P., M D. Sadick, B J. Holaday, R L. Coffman, and R M Locksley. 1989 Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 169:59.
21. Yamamura, M., K. Uyemura, R J. Deans, K. Weinberg, T. H. Rea, B. R Bloom, and R. L. Modlin. 1991 Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277
22. Zwingenberger, K., A. Hohmann, M. Cardoso De Brito, and M. Ritter. 1991. Impaired balance of interleukin-4 and interferon-γ production in infections with Schistosoma mansoni and intestinal nematodes. Scand. J. Immunol 34:243.
23. + T lymphocytes in atopic patients. J. Immunol. 144.4651.
24. H2-like bronchoalveolar T-lymphocyte population in atopic asthma N. Engl J. Med 326:298.
25. H2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92 313.
26. Lee, H. J , I. Matsuda, Y. Naito, T. Yokota, N. Arai, and K. Arai. 1994. Signals and nuclear factors that regulate the expression of interleukin-4 and interleukin-5 genes in helper T cells. J. Allergy Clin. Immunol. 94.594
27. Todd, M. D , M. J Grusby, J. A Lederer, E. Lacy, A. H. Lichtman, and L. H. Glimcher. 1993. Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J. Exp. Med. 177:1663.
28. Henkel, G., and M. A Brown. 1994. PU 1 and GATA. components of a mast cell-specific interleukin 4 intronic enhancer. Proc. Natl. Acad. Sci. USA 91:7737.
29. Li-Weber, M., H. Kraft, and P. H. Krammer. 1993. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. J. Immunol. 151.1371.
30. Szabo, S J. J. S. Gold, T. L. Murphy, and K. M. Murphy. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13:4793
31. Sorg, R. V., J Enczmann, U. R. Sorg, E. M Schneider, and P Wernet. 1993. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. Exp. Hematol. 21:560.
32. Alms, W. J., S. P. Atamas, V. V Yurovsky, and B White. 1996. Generation of an alternative splice variant of human IL-4 Mol. Immunol. In press.
33. Caceres, J. F , S. Stamm, D M. Helfman, and A. R. Kramer. 1994. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265:1706.
34. Hodges, D., and S. I Bernstein 1994 Genetic and biochemical analysis of alternative RNA splicing. Adv. Genet. 31:207.
35. Coughlin, S. R. 1994 Expanding horizons for receptor coupled to G protein: diversity and disease Curr. Opin. Cell Biol. 6:191
36. Boyd, C. D., R. A. Pierce, J. E. Schwarzbauer, K. Doege, and L. J. Sandell. 1993. Alternate exon usage is a commonly used mechanism for increasing coding diversity within genes coding for extracellular matrix proteins. Matrix 13:457.
37. Futatsugi, A., G. Kuwajiama, and K. Mikoshiba. 1995. Tissue-specific and developmentally regulated alternative splicing in mouse skeletal muscle ryanodine receptor mRNA. Biochem. J 305:373.
38. Huang, J. P., C. J Tang, G. H. Kou, V. T. Marchesi, E. J. Benz, and T K Tang 1993. Genomic structure of the locus encoding protein 4 1.: structural basis for complex combinatorial patterns of tissue-specific alternative RNA splicing. J Biol Chem. 268:3758
39. Michaelis, E. K. 1993 Two different families of NMDA receptors in mammalian brain: physiological function and role in neuronal development and degeneration. Adv. Exp. Med. Biol. 341:119.
40. Craig, W., S. Poppema, M T. Little, W. Dragowska, and P. M. Lansdorp 1994. CD45 isoform expression on human haemopoetic cells at different stages of development. Br. J. Haematol 88:24.
41. Pals, S. T., G. Koopman, K. H. Heider, A. Griffioen, G. R. Adolf. F. Van den Berg, H. Ponta, P Herrlich, and E. Horst. 1993. CD44 splice variants, expression during lymphocyte activation and tumor progression. Behring Inst Mitt. 92.273.
42. Alterman, R L , and E. R. Stanley. 1994. Colony-stimulating factor-1 expression in human glioma. Mol. Chem. Neuropathol. 21:117
43. Ohtsuki, T., M. Ikeda, K. Hatake, H Tomizuka, Y. Hoshino, S. Suzu, K. Harigaya, K. Motoyoshi, and Y. Miura 1994. Quantitative analysis of the two macrophage colony-stimulating factor mRNA expressed in a human stromal cell line by reverse transcription-polymerase chain reaction. Biochim. Biophys Acta 222:141.
44. Kitamura, N., K. Miyazawa, Y. Uehara, M. Komada, A. Okajima, M. Okigaki, and A. Kitamura. 1993. Gene expression and regulation of HGF-SF. EXS 65:49.
45. Chromczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
46. Upcroft, P., and A. Healey. 1987. Rapid and efficient method for cloning of blunt-ended DNA fragments. Gene 51:69.
47. Nicoletti, V. G., and D. F. Condorelli. 1993 Optimized PEG method for rapid plasmid DNA purification, high yield from "midi-prep". Biotechniques 14:532.
48. Edge, A. S. B., C. R Faltinek, L. Hof, L. E. Reicher, and P Weber. 1981. Deglycosylation of glycoproteins by trifluoromethanesulfonic acid. Anal. Biochem. 118:131
49. Mach, H., C. R. Middaugh, and R. V. Lewis. 1992. Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal. Biochem 200:74.
50. Braga, V. M., and S. J Gendler 1994 Co-amplification of two CDNAs in RT-PCR can alter the yield of both products Biotechniques 17:228.
51. Barr, K. A., S. A. Hopkins, and K. Sreekrishna. 1992. Protocol for efficient secretion of HSA developed from Pichia pastoris. Pharm. Eng. 12:48.
52. high human thymocytes are activated and already functionally differentiated into helper and cytotoxic cells. J. Immunol. 152:1738.
53. Poulter, L. W., A. Norris, C. Power, A. Condez, B. Schmekel, and C. Burke, 1992 Eur Respir. J. 5:182.
54. Kaltreider, H. B., and S E. Salmon 1973 Immunology of the lower respiratory tract: functional properties of bronchoalveolar lymphocytes obtained from the normal canine lung. J. Clin. Invest. 52:2211
55. Kirby, J., A. Wood, J. Reader, K. Isted, J. Hynd, D. Hawkes, L. Hudson, and J Pepper 1985. Origin and immunological hyporeactivity of canine alveolar lymphocytes. Immunology 55:531.
56. Arai, N , D. Nomura, D. Villaret, R. Malefijt W. deWaal, M Seiki, M. Yoshida, S Minoshima, R. Fukuyama, M. Maekawa, J. Kudoh, N Shimizu, K Yokata, E Abe, T. Yokata, Y. Takebe, and K. Arai. 1989 Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J. Immunol. 142: 274.
57. Powers, R., D. S. Garrett, C. J March, E. A. Frieden, A. M. Gronenborn, and G M. Clore. 1992. Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. Science 256:1673
58. Zurawski, S. M., F. Vega Jr., B. Huyghe, and G. Zurawski. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12.2663.
59. Kruse, N., T. Lehmbecher, and W. Sebald. 1991. Site-directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferation activity of human interteukin-4. FEBS Lett. 286:58.
60. Kruse, N , B -J. Shen, S. Arnold, H. P. Tony, T. Muller, and W. Sebald. 1993. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 12.5121.
61. Russell, S. M , A D. Keegan, H. Harada, Y Nakamura, M. Noguchi, P. Leland, M. C Freidman, A Miyajima, R. K. Puri, W. E. Paul, and W. J. Leonard 1993. The interleukin-2 receptor γ chain is a functional component of the interleukin-4 receptor Science 262:1877
62. Kondo, M., T. Takeshita, N Ishii, M Nakamura, S. Watanabe, K. Arai, and K. Sugamura. 1993. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874.
63. C chain does not function as a subunit shared by the IL-4 and IL-13 receptors, implications for the structure of the IL-4 receptor. J. Immunol. 155:9.
64. Kimmenade, A. V., M. W. Bond, J. H. Schumacher, C. Laquoi, and R. A. Kastelein. 1988. Expression, renaturation and purification of recombinant human interleukin 4 from Escherichia coli. Eur J. Biochem. 173:109.
65. Larrick, J. W., and S C. Wright. 1992. Native cytokine antagonists. Baillieres Clin. Haematol 5:681.